Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 21 EP applications Thomas Haefele Racin has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11776453

USE OF ACTIVE PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CONDITIONS

IPC classification:
A61K 31/4439, A61K 31/551, A61P 25/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11791572

NOVEL TRIAZOLE COMPOUNDS III

IPC classification:
A61K 31/4192, A61P 25/00, C07D 401/14, C07D 403/04, C07D 405/14, C07D 413/14, C07D 417/14, C07D 491/107
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12719356

NOVEL BENZOFURANE-PIPERIDINE COMPOUNDS

IPC classification:
A61K 31/343, A61K 31/4525, A61P 25/18, C07D 405/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14168581

ISOXAZOLO-PYRIDINE DERIVATIVES

IPC classification:
A61K 31/4439, A61P 25/28, C07D 413/12, C07D 413/14, C07D 417/14, C07D 487/04, C07D 491/08, C07D 491/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Haefele Racin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12772789

SOLID FORMS OF 1,L-DIOXO-4-THIOMORPHOLINYL)-[6-[[3(4-FLUOROPHENYL)-5-METHYL-4-ISOXAZOLYL]METHOXY]-3-PYRIDINYL]-METHANONE

IPC classification:
A61K 31/541, A61P 25/28, C07D 401/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12772788

PROCESS FOR THE PREPARATION OF ISOXAZOLYL-METHOXY-NICOTINIC ACIDS

IPC classification:
C07D 413/12, C07D 413/14, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13774129

CELL PENETRATING PEPTIDES WHICH BIND IRF5

IPC classification:
C07K 14/47
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13774418

MACROCYCLIC KETOAMIDE IMMUNOPROTEASOME INHIBITORS

IPC classification:
A61K 38/05, A61P 29/00, C07K 5/062, C07K 5/065
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13767013

KETOAMIDE IMMUNOPROTEASOME INHIBITORS

IPC classification:
A61P 29/00, C07K 5/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13796097

SUBSTITUTED TRIAZOLE AND IMIDAZOLE COMPOUNDS

IPC classification:
A61K 31/415, A61K 31/4164, A61K 31/4192, A61K 31/4196, A61P 1/00, A61P 19/02, C07D 233/90, C07D 249/04, C07D 249/10, C07D 401/12, C07D 403/06, C07D 403/12, C07D 405/12, C07D 409/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Haefele Racin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13798328

SUBSTITUTED TRIAZOLE BORONIC ACID COMPOUNDS

IPC classification:
A61K 31/69, A61P 29/00, C07F 5/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13799602

NOVEL BI-RING PHENYL-PYRIDINES/PYRAZINES FOR THE TREATMENT OF CANCER

IPC classification:
C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14769665

POLYCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
A61K 31/4152, A61K 31/426, A61P 3/00, A61P 3/04, A61P 3/10, C07D 231/10, C07D 277/20
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14813526

AZETIDINE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
A61K 9/06, A61K 9/08, A61K 31/397, A61P 35/00
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14812952

ESTROGEN RECEPTOR MODULATOR AND USES THEREOF

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/397, A61P 35/00
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP11793807

NOVEL BENZOFURANE COMPOUNDS

IPC classification:
A61K 31/505, A61P 25/18, C07D 405/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Haefele Racin, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15154342

Compounds for the treatment of cancer

IPC classification:
A61K 31/433, A61K 31/435, A61K 31/4353, A61K 31/437, A61K 31/438, A61K 31/4436, A61K 31/454, A61K 31/4545, A61K 31/4709, A61K 31/501, A61K 31/502, A61K 31/506, A61K 31/5377, A61K 31/551, A61K 45/06, A61P 35/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
APPLICATION REFUSED
EP11728861

ANELLATED PYRIDINE COMPOUNDS

IPC classification:
A61K 31/496, A61P 25/18, A61P 25/22, A61P 25/24, A61P 25/28, A61P 25/30, C07D 491/048, C07D 495/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Haefele Racin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12705101

NOVEL BENZODIOXOLE PIPERAZINE COMPOUNDS

IPC classification:
A61K 31/36, A61P 25/18, C07D 317/66, C07D 405/12, C07D 407/12, C07D 409/12, C07D 413/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Thomas Haefele Racin, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15166641

SOLID FORMS

IPC classification:
C07C 209/62, C07C 209/84, C07C 211/36
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
APPLICATION PUBLISHED
EP14827261

ESTROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC ESTROGEN RECEPTOR POSITIVE BREAST CANCER

IPC classification:
A61K 31/416, A61P 35/00, A61P 35/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature